MALASEK ROBERT 4
4 · AXIM BIOTECHNOLOGIES, INC. · Filed Mar 19, 2024
Insider Transaction Report
Form 4
Transactions
- Award
Convertible Note
2024-03-15$53500.00/sh+53,500$2,862,250,000→ 3,475,000 totalExercise: $0.02From: 2024-03-15Exp: 2034-03-01→ Common Stock (2,675,000 underlying)
Footnotes (1)
- [F1]Reporting Person acquired a Convertible Note face $53,500. The Note is convertible into shares of the Issuers common stock at a price of $0.02 per share.